Federation Des Caisses Desjardins Du Quebec Jazz Pharmaceuticals PLC Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.4 Billion
Q4 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 485 shares of JAZZ stock, worth $69,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares

485

Previous 485 -0.0%

Holding current value

$69,612

Previous $54,000 9.26%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$103.94 - $118.98 $2.93 Million - $3.36 Million	-28,222 Reduced 98.31%	485 $51,000
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $3.31 Million - $3.81 Million	28,707 New	28,707 $3.47 Billion
Q4 2023 Aug 14, 2024	BUY	$114.26 - $136.0 $482,862 - $574,736	4,226 Added 149.7%	7,049 $867 Million
Q2 2023 Aug 14, 2024	SELL	$122.5 - $147.16 $413,070 - $496,223	-3,372 Reduced 54.43%	2,823 $350 Million
Q1 2023 Aug 14, 2024	BUY	$133.98 - $160.47 $758,326 - $908,260	5,660 Added 1057.94%	6,195 $907 Million
Q4 2022 Aug 14, 2024	SELL	$129.72 - $159.85 $354,784 - $437,189	-2,735 Reduced 83.64%	535 $85.2 Million
Q2 2022 Aug 14, 2024	SELL	$141.59 - $168.66 $6,371 - $7,589	-45 Reduced 1.36%	3,270 $510 Million
Q1 2022 Aug 14, 2024	BUY	$129.64 - $160.7 $366,881 - $454,780	2,830 Added 583.51%	3,315 $516 Million
Q3 2021 Aug 30, 2024	BUY	$128.64 - $184.79 $63,676 - $91,471	495 Added 17.55%	3,315 $431 Million
Q2 2021 Aug 30, 2024	BUY	$160.2 - $186.42 $374,067 - $435,290	2,335 Added 481.44%	2,820 $500 Million
Q4 2020 Aug 30, 2024	BUY	$140.71 - $165.05 $333,201 - $390,838	2,368 Added 523.89%	2,820 $466 Million
Q3 2020 Aug 30, 2024	SELL	$105.46 - $144.13 $1.89 Million - $2.58 Million	-17,934 Reduced 97.54%	452 $64.5 Million
Q2 2020 Aug 30, 2024	BUY	$95.68 - $121.88 $493,421 - $628,535	5,157 Added 38.98%	18,386 $2.04 Billion
Q1 2020 Aug 30, 2024	SELL	$87.74 - $152.74 $416,940 - $725,820	-4,752 Reduced 26.43%	13,229 $1.33 Billion
Q4 2019 Aug 30, 2024	BUY	$117.65 - $153.73 $553,190 - $722,838	4,702 Added 35.41%	17,981 $2.68 Billion
Q3 2019 Aug 30, 2024	BUY	$125.18 - $143.24 $1.61 Million - $1.84 Million	12,844 Added 2952.64%	13,279 $1.7 Billion
Q4 2018 Aug 30, 2024	SELL	$115.94 - $166.74 $5,797 - $8,337	-50 Reduced 10.31%	435 $53.9 Million
Q2 2018 Aug 30, 2024	SELL	$146.33 - $183.18 $5,121 - $6,411	-35 Reduced 7.45%	435 $75 Million
Q1 2018 Aug 30, 2024	SELL	$135.59 - $157.16 $10,169 - $11,787	-75 Reduced 13.76%	470 $71 Million
Q3 2017 Aug 30, 2024	BUY	$142.62 - $155.6 $10,696 - $11,670	75 Added 15.96%	545 $79.7 Million
Q1 2017 Aug 30, 2024	SELL	N/A	-15	470 $68.2 Million

Others Institutions Holding JAZZ

# of Institutions

544

Shares Held

59M

Call Options Held

125K

Put Options Held

58.4K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $9B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Jazz Pharmaceuticals PLC Transaction History